Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (22)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Paulus, W.
Right arrow Articles by Steinhoff, B. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paulus, W.
Right arrow Articles by Steinhoff, B. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol. 119, No. 2, 539-549, 1996
© 1996 Oxford University Press


research-article

The effect of anti–epileptic drugs on visual perception in patients with epilepsy

Walter Paulus, Guntram Schwarz and Bernhard J. Steinhoff

Department of Clinical Neurophysiology, Georg August University Göttingen, Germany

Correspondence to: Correspondence to: W. Paulus, Department of Clinical Neurophysiology, Georg-August-Universität Göttingen, Robert Koch Str. 40, D-37075 Göttingen, Germany

We investigated the influence of the antiepileptic drugs carbamazepine (CBZ), phenytoin (PHT) and valproic acid (VPA) on different aspects of visual perception in patients with epilepsy by three different methods. (i) The colour arrangement test Farnsworth Munsell D100. (ii) A monitor system generating 24 different Gaussian dots and 24 different vertical sinusoidal gratings. Luminance increments and decrements for achromatic discrimination and four different colours for chromatic discrimination were investigated with four different sizes each adding up to 24 stimuli. (iii) A Maxwellian view system providing a foveal blue test light either superimposed on a yellow adaptation field (increment threshold) or after switching off this field (postadaptation threshold). Five different adaptation levels were investigated. Patients on PHT offered the most abnormalities, particularly in the D100 and in all Gaussian dots recordings. The individual differences between increment and postadapation threshold (transient tritanopia effect) were significantly elevated at the four higher adaptation levels, whereas no change was found in the increment thresholds and only for the highest luminance level in the postadaptation thresholds. With VPA, chromatic and achromatic increment discrimination was impaired particularly for larger Gaussian stimuli on the monitor system. Valproic acid also induced a consistent increment threshold increase on the Maxwellian view system, an increase of the postadaptation threshold at the highest luminance level and, like PHT, an increase of the threshold differences at level 3 and 4, but not at the highest background level 5. Patients on CBZ provided normal results in all investigations, with the exception of a slight but significant increase in the D100 error score. Sinusoidal gratings turned out to be much less sensitive than Gaussian dots since they remained unchanged in patients on all three drug groups.

epilepsy; vision; psychophysics; drug effect; transmitter

Received June 1, 1995. Revised December 2, 1995. Accepted December 8, 1995.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
PsychosomaticsHome page
M. M. Shores and K. L. Sloan
Phenytoin-Induced Visual Disturbances Misdiagnosed as Alcohol Withdrawal
Psychosomatics, August 1, 2002; 43(4): 335 - 336.
[Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M C Lawden, T Eke, C Degg, G F A Harding, and J M Wild
Visual field defects associated with vigabatrin therapy
J. Neurol. Neurosurg. Psychiatry, December 1, 1999; 67(6): 716 - 722.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.